Comment on “KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study”

Amy Hughes, Jade Clarson, Tessa Gargett, Wenbo Yu, Michael P. Brown, Angel F. Lopez, Timothy P. Hughes, Agnes S M Yong

Research output: Contribution to journalEditorialpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)55-57
Number of pages3
JournalLeukemia Research
Publication statusPublished or Issued - 1 Apr 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this